VTV THERAPEUTICS INC - CL A (VTVT)

Q2 2020 13F Holders as of 30 Jun 2020

Type / Class
Equity / CL A
Total 13F shares
3,601,008
Share change
+1,276,863
Total reported value
$8,101,826
Price per share
$2.25
Number of holders
38
Value change
+$2,908,554
Number of buys
32
Number of sells
9

Institutional Holders of VTV THERAPEUTICS INC - CL A (VTVT) as of Q2 2020

As of 30 Jun 2020, VTV THERAPEUTICS INC - CL A (VTVT) was held by 38 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 3,601,008 shares. The largest 10 holders included FRAZIER MANAGEMENT LLC, VANGUARD GROUP INC, TWO SIGMA INVESTMENTS, LP, BlackRock Inc., STATE STREET CORP, GEODE CAPITAL MANAGEMENT, LLC, TWO SIGMA ADVISERS, LP, Virtu Financial LLC, NORTHERN TRUST CORP, and RENAISSANCE TECHNOLOGIES LLC. This page lists 38 institutional shareholders reporting positions in this security for the Q2 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.